HOLX Stock Analysis: Buy, Sell, or Hold?
HOLX - Hologic Inc
$74.93
-0.05 (-0.07%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 03, 2026
2d
Get Alerted When HOLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HOLX shows positive signals but monitor for confirmation. Market pricing in 5.4% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: HOLX shows positive signals but monitor for confirmation. Market pricing in 5.4% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$50.51
Based on -4.4% avg growth
INTRINSIC VALUE TODAY
$31.37
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HOLX is currently trading at $74.93, which is considered fair relative to its 30-day fair value range of $74.66 to $75.12. From a valuation perspective, the stock is trading at a premium (Forward PE: 18.9) compared to its historical average (16.1). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HOLX is in a strong uptrend. The price is approaching resistance at $75.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HOLX is in a strong uptrend. The price is approaching resistance at $75.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$74.66 -
$75.12
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($76.92)
- NEUTRAL: Trading at premium valuation - market expects 5.4% growth which is achievable
Fair Price Analysis
30-Day Fair Range
$74.66 -
$75.12
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$72.28
Resistance Level
$75.36
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
18.90
Wall Street Target
$76.92
(+2.6%)
Revenue Growth (YoY)
6.2%
Earnings Growth (YoY)
11.1%
Profit Margin
13.8%
Valuation Premium vs History
+5.4% premium
PE vs Historical
18.9 vs 16.1
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.4%
(market-implied from PE analysis)
1-Year Target
$79.03
(+5%)
2-Year Target
$83.30
(+11%)
3-Year Target
$87.79
(+17%)
3-Yr Target (if PE normalizes)
(PE: 19→16)
PE COMPRESSION
$74.79
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -12.8%)
$64.50
(+-14%)
Base:
(SPY PE: 18.9, Growth: -12.8%)
$54.66
(-27%)
Bear:
(PE: 16.1, Growth: -12.8%)
$46.46
(-38%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 30.16 | Current EPS (TTM): $2.49
Bull Case
$131.63
(+76%)
Analyst growth 59.3%, PE expands to 33.2
Base Case
$119.66
(+60%)
Market implied 59.3%, PE stable at 30.2
Bear Case
$51.07
(-32%)
Severe decline -20.0%, PE contracts to 25.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 31, 2026 6:11 AM ET
Data refreshes hourly during market hours. Next update: 7:11 AM
Data refreshes hourly during market hours. Next update: 7:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HOLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Christiana Stamoulis
SELL
7402 shares
2025-10-20
Stephen P Macmillan
SELL
138358 shares
2025-09-22
Ro Khanna
SELL
2025-09-04
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced HOLX Option Strategies
Professional options setups generated by AI based on today's HOLX price and gamma walls.
